MarketWatch

It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.

U.S. stock-index futures were erasing early losses on Sunday, after a massive tech selloff on Friday interrupted Wall Street’s two-month rally, and after new developments threatened the fragile cease-fire in the Iran war.

Investors are suddenly dumping technology stocks and rotating into other areas — including health insurers, banks and retailers.

A remarkable two-month sprint higher for major stock-market indexes encountered its first major hiccup on Friday as the Nasdaq Composite plummeted more than 1,121 points — the biggest one day point drop on record, according to Dow Jones Market Data.

Only seven companies cited oil prices as a reason for cutting or not updating their profit outlooks for the year.

“I generally withdraw money from my traditional 401(k) for projects, larger expenses and sometimes just to stay ahead on upcoming bills.”

There is a new wave of weight-loss therapies in development that aim to be better than the existing GLP-1s.